News

Other news

Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment

By JLABS

Read full story
In the media

Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation

By Lori Ioannou

Read full story
In the media

Healthmakers: Tom Luby - JLABS, Texas

By HighDriveTV

Read full story
In the media

When Fashion Saves Lives: Daymond John Discusses the Lab Coat of the Future

By Kate Sullivan

Read full story
Other news

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

By Ideaya Biosciences

Read full story
In the media

To stay on cutting edge, major corporations like Johnson & Johnson seek innovation within, outside their walls

By Will Anderson

Read full story
In the media

Five Questions For: Melinda Richter, Global Head at JLABS

By Angela Shah

Read full story
In the media

Texas Med Center Playing Catch-Up On Commercialization

By Kyle Hagerty

Read full story
Press release

Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge

By JLABS

Read full story
Press release

Johnson & Johnson Innovation launches Singapore QuickFire Challenge Competition in collaboration with ETPL and SMART to accelerate solutions for diabetes and other metabolic diseases

By JLABS

Read full story
In the media

JLABS @ TMC Celebrates One-Year Anniversary

By Christine Hall

Read full story
In the media

An Audience With... Melinda Richter, Head of JLABS at Johnson & Johnson Innovation

By -

Read full story
In the media

New biotech incubator gives fledgling companies a boost

By Jenny Deam

Read full story
In the media

Four Reasons an Accelerator Program May Be Right for You

By Springboard Enterprises | Lucia Mokres

Read full story
In the media

Johnson & Johnson Chooses Houston For Next Start-Up Business Accelerator

By Carrie Feibel

Read full story